Glucagon-like Peptide 2 (Human)

Documents

His-Ala-Asp-Gly-Ser-Phe-Ser-Asp-Glu-Met-Asn-Thr-Ile-Leu-Asp-Asn-Leu-Ala-Ala-Arg-Asp-Phe-Ile-Asn-Trp-Leu-Ile-Gln-Thr-Lys-Ile-Thr-Asp
: (M.W. 3766.1) C₁₆₅H₂₅₄N₄₄O₅₅S
: Food Intake Suppressor

Package	Price(Yen)	Availability
Vial 0.5 mg	29,000	Ships within 1-3 business days
Bulk Request

Solubility: 25 mM Phosphate buffer (pH 7.4) or 0.1% NH4OH (0.1 mM)

B. Hartmann, A.H. Johnsen, C. Ørskov, K. Adelhorst, L. Thim, and J.J. Holst, Peptides, 21, 73 (2000). (Pharmacol.)
M. Tang-Christensen, P.J. Larsen, J. Thulesen, J. Rømer, and N. Vrang, Nat. Med., 6, 802 (2000). (Pharmacol.)
D.J. Drucker, Gut, 50, 428 (2002). (Review)
K. Wallis, J.R.F. Walters, and A. Forbes, Aliment. Pharmacol. Ther., 25, 365 (2007). (Review)
P.E. Dubé and P.L. Brubaker, Am. J. Physiol. Endocrinol. Metab., 293, E460 (2007). (Review)
K.J. Rowland and P.L. Brubaker, Mol. Cell. Endocrinol., 288, 63 (2008). (Review)
R. Yazbeck, G.S. Howarth, and C.A. Abbott, Cytokine Growth Factor Rev., 20, 175 (2009). (Review)
R. Yazbeck, C.A. Abbott, and G.S. Howarth, Curr. Opin. Investig. Drugs, 11, 440 (2010). (Review)
E. Blázquez, E. Alvarez, M. Navarro, I. Roncero, F. Rodriíguez-Fonseca, J.A. Chowen, and J.A. Zueco, Mol. Neurobiol., 18, 157 (1998). (Review)
G. van Dijk and T.E. Thiele, Neuropeptides, 33, 406 (1999). (Review)

Data Sheet